NVC

CodePR Brings on Industry Veteran and Former Head of VC Practice at Sparkpr

Retrieved on: 
Friday, May 3, 2024
NVC, The, IVP, DCM, Verizon Communications, NEA, Partner, Virgin Green Fund, Marketing, SAN

SAN FRANCISCO, May 3, 2024 /PRNewswire/ -- CodePR, a boutique communications agency amplifying the brands of VC firms and innovative startups, today announced that Tim Turpin, former Sparkpr Executive Vice President and head of its Venture Capital and Emerging Technologies Practice, has joined as a Partner.

Key Points: 
  • He rejoins his former colleagues Mary Magnani and Michael Celiceo, who founded the firm three years ago and have built an impressive roster of VC clients.
  • "We started CodePR to provide senior support to venture capital firms of all sizes looking to raise their profile with specific audiences," said co-founder Mary Magnani.
  • Turpin was recruited into Sparkpr in 2007 and successfully built the firm's venture capital practice.
  • "I'm excited for this next phase in my career of partnering with investors and entrepreneurs while helping CodePR continue to work with only the best firms."

2024 Harvard Business School New Venture Competition: Uniting Cutting Edge Ideas, Innovative Ventures, and Talented Alumni and Students

Retrieved on: 
Friday, March 29, 2024
HubSpot, Uncertainty, Climate change, Organization, Farmer, Learning, Mentorship, NVC, Harvard Innovation Labs, Partnership, MassChallenge, Complex, Accounting, Entrepreneurship, Patient, BEAM, Artificial intelligence, AI, HBS, Wix, Faculty, Student, MBA, Clayton, Dubilier & Rice, Sacerdote, Dubilier, Cosmetics, Social change, School, Management

The NVC is open to all students and alumni interested in launching new business and social impact ventures.

Key Points: 
  • The NVC is open to all students and alumni interested in launching new business and social impact ventures.
  • The School's Arthur Rock Center for Entrepreneurship and Social Enterprise Initiative (SEI), in partnership with HBS Alumni Clubs & Associations , host the annual competition.
  • Students engage in collaborative efforts with peers and receive pragmatic feedback from a deep bench of serial entrepreneurs and early-stage investors.
  • Peter M. Sacerdote $25,000 Runner Up Prize:
    A tool built by the trans community that addresses clinicians' barriers around learning and advocacy.

Aerin Medical Announces New Positive Two-Year Results from VivAer® AERWAY Study

Retrieved on: 
Thursday, July 13, 2023
Science, Biotechnology, Research, Pharmaceutical, Medical Supplies, Health, Medical Devices, Clinical Trials, ENT, American Academy of Otolaryngology–Head and Neck Surgery, NVC, Head, McGovern Medical School, American Academy, Multimedia, Otorhinolaryngology, Nose, Network congestion, Patient, Physician, Randomized controlled trial, Steroid, NAO, Ear, Safety, Pharmaceutical industry

Results featured in Laryngoscope Investigative Otolaryngology showed a significant and long-term improvement in NAO symptom burden.

Key Points: 
  • Results featured in Laryngoscope Investigative Otolaryngology showed a significant and long-term improvement in NAO symptom burden.
  • A non-invasive technology developed by Aerin Medical Inc., VivAer uses patented, temperature-controlled radiofrequency energy to provide long-term relief from nasal obstruction.
  • The AERWAY study, a prospective, multi-center trial, followed patients after a single treatment session with VivAer and collected two-year outcomes for 91 patients.
  • “The positive two-year outcomes from the AERWAY trial build upon published VivAer clinical results, including superior symptom improvements in a randomized controlled trial and a four-year study showing long-term durability of a single VivAer treatment,” said Matt Brokaw, CEO of Aerin Medical.

Aerin Medical Supports AAO-HNS Position Recognizing Nasal Valve Repair as a Distinct Procedure that Improves Nasal Obstruction Symptoms

Retrieved on: 
Tuesday, April 18, 2023
Research, Medical Devices, Surgery, Medical Supplies, FDA, Other Health, General Health, Health, Science, Other Science, ENT, American Academy of Otolaryngology–Head and Neck Surgery, Failure, AAO, NVC, Otorhinolaryngology, Airway obstruction, American Academy, Multimedia, Nose, Network congestion, Patient, Physician, Steroid, NAO, Ear, Pharmaceutical industry

The statement recognizes nasal valve repair as “a distinct surgical procedure that can improve nasal obstruction symptoms for appropriately selected patients.” The Academy notes that office-based techniques, including radiofrequency treatment, can stabilize the nasal valve, optimize nasal valve collapse (NVC) patient outcomes, and be performed either as a standalone procedure or in combination with other procedures to potentially avoid multiple surgeries.

Key Points: 
  • The statement recognizes nasal valve repair as “a distinct surgical procedure that can improve nasal obstruction symptoms for appropriately selected patients.” The Academy notes that office-based techniques, including radiofrequency treatment, can stabilize the nasal valve, optimize nasal valve collapse (NVC) patient outcomes, and be performed either as a standalone procedure or in combination with other procedures to potentially avoid multiple surgeries.
  • View the full release here: https://www.businesswire.com/news/home/20230418005388/en/
    New guidance from the American Academy of Otolaryngology-Head and Neck Surgery notes that radiofrequency treatments can be used to stabilize the nasal valve and optimize nasal valve collapse (NVC) patient outcomes.
  • VivAer, a non-invasive technology developed by Aerin Medical, uses temperature-controlled radiofrequency energy to provide long-term relief from nasal obstruction caused by NVC.
  • “Nasal airway obstruction is one of the primary reasons a patient visits an ENT physician, and we hope that this enables ENTs to treat nasal valve collapse with minimally invasive solutions when it contributes to nasal obstruction.”

SmartRyde, Inc., the Operator of a Pre-booked Airport Transfer Marketplace “SmartRyde,” Introduces “Demand Partner API”

Retrieved on: 
Monday, April 10, 2023
Software, Internet, Professional Services, Data Management, Vacation, Other Travel, Transportation, Technology, Lodging, Destinations, Travel, Finance, Online, Japan Finance Corporation, NVC, Head, OTA, API, GDS, VCS, NEC, Airline, Bank

GDS is an online network that connects travel agencies and other travel-related service providers such as airlines, hotels and car rental agencies around the world.

Key Points: 
  • GDS is an online network that connects travel agencies and other travel-related service providers such as airlines, hotels and car rental agencies around the world.
  • This system allows their customers to make real-time reservations and enables real-time ticket issuance.
  • With this funding, we will invest further in expanding corporate functions and building strengths of business teams as well as in product development.
  • SmartRyde also aims to support domestic taxi operators in the aspect of profitability and to provide them with new value including streamlining and cost reduction.

2023 HBS New Venture Competition: Bringing Out the Best in HBS Students and Alumni, with Ideas and Ventures to Change the World

Retrieved on: 
Friday, March 31, 2023
Harvard Innovation Labs, Hair, Water pollution, MBA, HubSpot, Harvard Business School, Accounting, Science, Entrepreneurship, Soil, Health care, Sacerdote, Industrial waste, Rock Center with Brian Williams, Therapy, NVC, Cosmetics, HBS, Organization, Wix, Nursing, Clayton, Dubilier & Rice, Baker Library, Business, Medicine, Garbage, Somatosensory system, Pando, Engineering, MassChallenge, Dubilier, Factorization of polynomials, Partnership, Education, Student, School, SEI, Artificial intelligence, AWS, Video game, Management, Foundry, Information technology, Online shopping

The NVC is open to all students and alumni interested in launching new business and social impact ventures.

Key Points: 
  • The NVC is open to all students and alumni interested in launching new business and social impact ventures.
  • The School's Arthur Rock Center for Entrepreneurship and Social Enterprise Initiative (SEI), in partnership with HBS Alumni Clubs & Associations , host the annual competition.
  • "While we're entering a world where exponential change is coming, things are already changing all around us," he noted.
  • This year there are three $5,000 Touch Tech Venture Awards for Most Promising Climate Tech, Deep Tech and Pharmaceutical Ventures.

Aerin Medical Announces CMS Set to Implement New CPT® Code for Temperature-Controlled Radiofrequency Repair of Nasal Valve Collapse

Retrieved on: 
Wednesday, November 16, 2022
Health, FDA, Medical Devices, Surgery, Health Insurance, Research, Science, NVC, Patient, FDA, Centers for Medicare & Medicaid Services, CMS, CE marking, Network congestion, Multimedia, Freezing, Indian Medical Association, Medicare, AMA, ENT, Physician, CY, American Medical Association, Ear, Nose, CPT, Hospital

View the full release here: https://www.businesswire.com/news/home/20221116005226/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221116005226/en/
    CMS is set to implement a new CPT code that includes the use of VivAer to repair nasal valve collapse in the office and outpatient surgical settings.
  • VivAer is a non-invasive, temperature-controlled radiofrequency technology that provides long-term relief from nasal obstruction.
  • CPT code 30469, repair of NVC with low energy, temperature-controlled (i.e., radiofrequency) subcutaneous/submucosal remodeling, was established by the American Medical Association (AMA) describing use of VivAer for this procedure.
  • For more information, please visit www.aerinmedical.com and follow Aerin Medical on Facebook , Twitter , Instagram , LinkedIn and YouTube .

The Next Vision Capital Announces an Investment from IDG Capital Blockchain

Retrieved on: 
Monday, October 17, 2022
Investor, NVC, NFT, SEA, Technology, Convention center, AI, GLOBE, SME, Cryptocurrency, Blockchain

HANOI, VIETNAM, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Recently, the Next Vision Capital, a digital financial platform offering packages to SMEs, is proud to announce an Investment from IDG Capital Blockchain (IDGCB).

Key Points: 
  • HANOI, VIETNAM, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Recently, the Next Vision Capital, a digital financial platform offering packages to SMEs, is proud to announce an Investment from IDG Capital Blockchain (IDGCB).
  • IDG Capital Blockchain currently manages 40 million dollars and has been investing in over 30 companies under various sectors.
  • Having found the potential of Next Vision Capital (NVC) in the blooming age of Blockchain related technology, IDGCB has made the decision to invest in NVC.
  • On 6th October 2022, NVC held the Next Vision Capital Investment Show at Suntec Convention & Exhibition Center, to connect with investors in Singapore.

New 12-month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer® in Patients with Nasal Valve Collapse

Retrieved on: 
Tuesday, September 6, 2022
Science, Other Science, Research, Medical Supplies, Health, Medical Devices, Clinical Trials, Other Health, Otorhinolaryngology, ENT, Fatigue, JAMA Otolaryngology–Head & Neck Surgery, Technology, Division, Safety, CEO, NAO, YouTube, Nose, Exercise, Solution, Randomized controlled trial, International Forum of Allergy & Rhinology, Physician, LinkedIn, NVC, Ear, Network congestion, Headache, Quality of life, Multimedia, Sleep, Somnolence, Patient, Instagram, FDA, Eastern Virginia Medical School, Nasal congestion, Twitter, Excessive daytime sleepiness, Snoring, Prevalence, Epworth Sleepiness Scale, Freezing, CE marking, Adoption, Pharmaceutical industry, Birth control, Allergy, Facebook

This study demonstrates that treatment with VivAer is a compelling non-invasive alternative for NAO patients and reinforces physician confidence in the consistent and lasting results of this treatment.

Key Points: 
  • This study demonstrates that treatment with VivAer is a compelling non-invasive alternative for NAO patients and reinforces physician confidence in the consistent and lasting results of this treatment.
  • After primary endpoint analysis and unblinding, 31 patients were eligible for crossover, and all elected to undergo active VivAer treatment.
  • The VATRAC study outcomes demonstrate ongoing effectiveness and safety of VivAer, with treated patients reporting durable improvement from baseline at 12 months post-procedure.
  • 1 Silvers et al., Temperature-controlled radiofrequency device treatment of the nasal valve for nasal airway obstruction: A randomized controlled trial.

Four-Year Results Show Aerin Medical’s VivAer® Treatment Provides Significant, Sustained Relief of Nasal Obstruction Symptoms

Retrieved on: 
Wednesday, June 29, 2022
Health, Medical Devices, Surgery, Clinical Trials, Research, Science, Biotechnology, International Forum of Allergy & Rhinology, FDA, NAO, Patient, LinkedIn, Nose, CEO, Nasal congestion, Allergy, ENT, Population, Exercise, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NVC, YouTube, Otorhinolaryngology, Technology, CE marking, Freezing, Prevalence, Hofstra University, Ear, Instagram, Network congestion, Solution, Safety, Twitter, Physician, Multimedia, Norwegian Asthma and Allergy Association, Pharmaceutical industry, Facebook

The results showed the long-term durability of VivAer treatment for those with nasal airway obstruction (NAO) due to nasal valve collapse (NVC).

Key Points: 
  • The results showed the long-term durability of VivAer treatment for those with nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
  • In the follow-up study, patients experienced significant and sustained improvement in symptoms of NAO through four years following a single treatment of NVC with VivAer.
  • View the full release here: https://www.businesswire.com/news/home/20220629005192/en/
    Following treatment with VivAer, published data demonstrate significant and sustained improvement in symptoms of nasal airway obstruction due to nasal valve collapse through four years.
  • VivAer, a non-invasive technology developed by Aerin Medical Inc., uses temperature-controlled radiofrequency energy to provide long-term relief from nasal obstruction symptoms.